CNO Financial Group - CNO Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CNO Financial Group in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CNO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CNO, but not buy additional shares or sell existing shares.
View CNO analyst ratings or view top-rated stocks.

4 analysts have issued 1-year price targets for CNO Financial Group's shares. Their CNO share price forecasts range from $23.00 to $28.00. On average, they predict the company's share price to reach $25.50 in the next twelve months. This suggests a possible upside of 20.7% from the stock's current price.
View analysts price targets for CNO or view top-rated stocks among Wall Street analysts.

CNO Financial Group's stock was trading at $22.85 at the start of the year. Since then, CNO stock has decreased by 7.6% and is now trading at $21.12.
View the best growth stocks for 2023 here.

CNO Financial Group saw a drop in short interest in February. As of February 28th, there was short interest totaling 2,510,000 shares, a drop of 18.2% from the February 13th total of 3,070,000 shares. Based on an average daily trading volume, of 800,900 shares, the short-interest ratio is currently 3.1 days. Currently, 2.3% of the shares of the company are short sold.
View CNO Financial Group's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 1st 2023.
View our CNO earnings forecast.

CNO Financial Group, Inc. (NYSE:CNO) posted its quarterly earnings data on Tuesday, February, 7th. The financial services provider reported $0.56 earnings per share for the quarter, hitting the consensus estimate of $0.56. The financial services provider had revenue of $973.60 million for the quarter, compared to the consensus estimate of $910.10 million. CNO Financial Group had a trailing twelve-month return on equity of 12.74% and a net margin of 11.09%. The company's revenue for the quarter was down 9.4% compared to the same quarter last year. During the same period last year, the company earned $0.87 earnings per share.

CNO Financial Group announced a quarterly dividend on Wednesday, February 15th. Stockholders of record on Friday, March 10th will be paid a dividend of $0.14 per share on Friday, March 24th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 2.65%. The ex-dividend date of this dividend is Thursday, March 9th.
Read our dividend analysis for CNO.

ETFs with the largest weight of CNO Financial Group (NYSE:CNO) stock in their portfolio include SPDR S&P Insurance ETF (KIE), Invesco S&P MidCap Value with Momentum ETF (XMVM), ProShares Russell 2000 Dividend Growers ETF (SMDV), Invesco S&P MidCap 400 Pure Value ETF (RFV), Hartford Multifactor Small Cap ETF (ROSC), Syntax Stratified MidCap ETF (SMDY), iShares U.S. Insurance ETF (IAK) and iShares US Small Cap Value Factor ETF (SVAL).

CNO Financial Group (NYSE:CNO) pays an annual dividend of $0.56 per share and currently has a dividend yield of 2.54%. The company has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 16.62%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CNO will have a dividend payout ratio of 19.44% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CNO.

34 employees have rated CNO Financial Group Chief Executive Officer Gary C. Bhojwani on Glassdoor.com. Gary C. Bhojwani has an approval rating of 69% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other CNO Financial Group investors own include Inovio Pharmaceuticals (INO), AbbVie (ABBV), Energy Transfer (ET), Bank of America (BAC), Walt Disney (DIS), International Business Machines (IBM), Intel (INTC), Pfizer (PFE), AT&T (T) and Wells Fargo & Company (WFC).

CNO Financial Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNO."

CNO Financial Group's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Pzena Investment Management LLC (6.67%), Fuller & Thaler Asset Management Inc. (6.37%), Dimensional Fund Advisors LP (4.86%), LSV Asset Management (4.43%), AQR Capital Management LLC (2.38%) and Franklin Resources Inc. (2.33%). Insiders that own company stock include Bruce K Baude, Charles J Jacklin, David B Foss, Ellyn L Brown, Frederick James Sievert, Gary C Bhojwani, John R Kline, Matthew J Zimpfer, Paul H Mcdonough, Robert C Greving and Scott L Goldberg.
View institutional ownership trends.

Shares of CNO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CNO stock can currently be purchased for approximately $21.12.

CNO Financial Group (NYSE:CNO) has a market capitalization of $2.41 billion and generates $3.58 billion in revenue each year. The financial services provider earns $396.80 million in net income (profit) each year or $3.37 on an earnings per share basis.

The company employs 3,400 workers across the globe.

CNO Financial Group's mailing address is 11825 NORTH PENNSYLVANIA STREET, CARMEL IN, 46032. The official website for the company is www.cnoinc.com. The financial services provider can be reached via phone at (317) 817-6100, via email at jennifer.childe@cnoinc.com, or via fax at 317-817-2847.